Literature DB >> 10642289

Effect of continuous positive airway pressure on blood pressure : a placebo trial.

J E Dimsdale1, J S Loredo, J Profant.   

Abstract

This study examined the effect of continuous positive airway pressure (CPAP) treatment on blood pressure in patients with obstructive sleep apnea. Thirty-nine patients with sleep apnea were studied. Ambulatory blood pressure monitoring was obtained before and after patients were randomized to receive either 1 week of CPAP or placebo CPAP (CPAP administered at ineffective pressure). Blood pressure was examined over daytime hours (6 AM to 10 PM) and during nighttime hours (10 PM to 6 AM). Daytime mean arterial blood pressure decreased significantly but equally in both the active treatment group and the placebo treatment group (P=0.001). Nighttime mean arterial pressure levels decreased to a much greater extent over time in the patients who received active CPAP treatment (P=0. 032). CPAP does appear to decrease nighttime blood pressure. However, the decrease in daytime blood pressure may reflect a nonspecific response (ie, placebo), since both the active treatment group and the placebo treatment group developed comparable decreases in blood pressure.

Entities:  

Mesh:

Year:  2000        PMID: 10642289     DOI: 10.1161/01.hyp.35.1.144

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  57 in total

Review 1.  Are sleep-related breathing disorders important contributing factors to the production of essential hypertension?

Authors:  D S Silverberg; A Oksenberg
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 2.  Cardiovascular consequences of obese and nonobese obstructive sleep apnea.

Authors:  Kannan Ramar; Sean M Caples
Journal:  Med Clin North Am       Date:  2010-05       Impact factor: 5.456

3.  CPAP treatment supported by telemedicine does not improve blood pressure in high cardiovascular risk OSA patients: a randomized, controlled trial.

Authors:  Monique Mendelson; Isabelle Vivodtzev; Renaud Tamisier; David Laplaud; Sonia Dias-Domingos; Jean-Philippe Baguet; Laurent Moreau; Christian Koltes; Léonidas Chavez; Gilles De Lamberterie; Frédéric Herengt; Patrick Levy; Patrice Flore; Jean-Louis Pépin
Journal:  Sleep       Date:  2014-11-01       Impact factor: 5.849

4.  Exosomal Cargo Properties, Endothelial Function and Treatment of Obesity Hypoventilation Syndrome: A Proof of Concept Study.

Authors:  Rakesh Bhattacharjee; Abdelnaby Khalyfa; Ahamed A Khalyfa; Babak Mokhlesi; Leila Kheirandish-Gozal; Isaac Almendros; Eduard Peris; Atul Malhotra; David Gozal
Journal:  J Clin Sleep Med       Date:  2018-05-15       Impact factor: 4.062

Review 5.  Sleep . 6: obstructive sleep apnoea/hypopnoea syndrome and hypertension.

Authors:  G V Robinson; J R Stradling; R J O Davies
Journal:  Thorax       Date:  2004-12       Impact factor: 9.139

Review 6.  Sleep.7: positive airway pressure therapy for obstructive sleep apnoea/hypopnoea syndrome.

Authors:  P Gordon; M H Sanders
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

7.  The effect of oral appliance therapy on blood pressure in patients with obstructive sleep apnea.

Authors:  Ryo Otsuka; Fernanda Ribeiro de Almeida; Alan A Lowe; Wolfgang Linden; Frank Ryan
Journal:  Sleep Breath       Date:  2006-03       Impact factor: 2.816

8.  Variables affecting the change in systemic blood pressure in response to nasal CPAP in obstructive sleep apnea patients.

Authors:  Junaid Malik; Christopher L Drake; David W Hudgel
Journal:  Sleep Breath       Date:  2008-03       Impact factor: 2.816

Review 9.  Obstructive sleep apnea and the metabolic syndrome: The road to clinically-meaningful phenotyping, improved prognosis, and personalized treatment.

Authors:  Jordan Gaines; Alexandros N Vgontzas; Julio Fernandez-Mendoza; Edward O Bixler
Journal:  Sleep Med Rev       Date:  2018-09-03       Impact factor: 11.609

10.  Effects of nocturnal continuous positive airway pressure therapy in patients with resistant hypertension and obstructive sleep apnea.

Authors:  Tarek A Dernaika; Gary T Kinasewitz; Maroun M Tawk
Journal:  J Clin Sleep Med       Date:  2009-04-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.